An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Celea Therapeutics, based in the Greater Boston area with a hybrid work model, seeks an experienced Vice President of Regulatory Affairs to lead global strategy and agency interactions as deupirfenidone advances through Phase 3.
The role reports to the Chief Medical Officer and will own submissions across programs, build scalable processes, and mentor the regulatory team to drive toward registration and commercialization.
Celea Therapeutics is dedicated to advancing transformative treatments for people with serious respiratory diseases. Drawn from the Latin word for “sky,” our name reflects our mission to rise above the status quo and deliver therapies that change lives. Our lead program, deupirfenidone (LYT-100), is currently in Phase 3 clinical development with active candidate enrollment, representing a potential new standard of care for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.
As we prepare for our next stage of growth and clinical advancement, Celea is seeking an experienced, strategic, and hands‑on Vice President of Regulatory Affairs to lead our global regulatory strategy and serve as our primary advocate with the FDA and other international health authorities as we advance deupirfenidone (LYT-100) through Phase 3 development toward registration. Reporting to the Chief Medical Officer, this role will be a member of the Celea Leadership Team and will own regulatory strategy, agency interactions, and submissions across all of our development programs while also personally leading the preparation of high‑quality regulatory filings — from briefing documents and health authority meetings through the planned NDA/MAA.
In the near term, the focus will be supporting Phase 3 execution and the regulatory interactions and submissions that, together with our Phase 2b results, could serve as the basis for registration in the U.S. and other geographies. Over time, this person will build and scale the regulatory function, establish robust regulatory processes and infrastructure, and help prepare Celea for approval and commercialization, and will be instrumental in guiding Celea through its next chapter.
This position is based in the Greater Boston area, with a hybrid working model.
Rising above the status quo takes a team as strong as its science, and we hire and work by five values: accountability — owning outcomes and acting like owners; transparency — talking straight and building trust; collaboration — achieving together what no one could alone; innovation — challenging accepted ideas and taking smart risks; and passion — bringing energy and heart to the mission.
Transparency is one of our values, and that includes how we pay. The anticipated salary range for this role is $330,000 - $375,000 plus bonus and equity. Where an offer lands within the range reflects the candidate’s experience, skills, and internal equity — and we welcome open conversations about compensation from the first call, so there are no surprises at the offer stage.
Actual compensation will be determined based on experience, qualifications, and location. In addition to base pay, this role is eligible for bonus and equity compensation.
Base Pay Information: $330,000 USD - $375,000 USD
Celea Therapeutics is an equal opportunity employer. We evaluate every candidate against the requirements of the role using a structured, evidence‑based process, and we make employment decisions without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other legally protected characteristic.
For more information, visit www.celeatx.com or connect with us on Twitter @celeatx.